Monday, March 27, 2017 9:56:34 AM
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA) saw a significant drop in short interest in March. As of March 15th, there was short interest totalling 3,182,530 shares, a drop of 36.4% from the February 28th total of 5,004,312 shares. Approximately 4.8% of the company’s stock are short sold. Based on an average trading volume of 789,019 shares, the short-interest ratio is currently 4.0 days.
https://www.thecerbatgem.com/2017/03/27/short-interest-in-momenta-pharmaceuticals-inc-mnta-decreases-by-36-4.html
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM